Results 41 to 50 of about 1,946,248 (285)

Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug–Gene Interactions

open access: yesPharmaceutics, 2021
Drug repurposing is a valuable alternative to traditional drug design based on the assumption that medicines have multiple functions. Computer-based techniques use ever-growing drug databases to uncover new drug repurposing hints, which require further ...
Vlad Groza   +3 more
doaj   +1 more source

Drug repurposing in cancer

open access: yesPharmacological Research, 2017
Cancer is a major health issue worldwide, and the global burden of cancer is expected to increase in the coming years. Whereas the limited success with current therapies has driven huge investments into drug development, the average number of FDA approvals per year has declined since the 1990s.
Linda, Sleire   +5 more
openaire   +2 more sources

Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining [PDF]

open access: yesRoyal Society Open Science, 2018
Drug repurposing aims to find novel indications of clinically used or experimental drugs. Because drug data already exist, drug repurposing may save time and cost, and bypass safety concerns.
Tsang-Pai Liu   +3 more
doaj   +1 more source

Buying time: Drug repurposing to treat the host in COVID‐19H

open access: yesPharmacology Research & Perspectives, 2020
In 2016 Fedson stated …. “For almost two decades, leading scientists and health officials have warned that we must prepare for a potentially devastating global pandemic of an infectious disease. Initial concern was focused on …H5N1….
Jennifer H. Martin   +2 more
doaj   +1 more source

Network Crosstalk as a Basis for Drug Repurposing

open access: yesFrontiers in Genetics, 2022
The need for systematic drug repurposing has seen a steady increase over the past decade and may be particularly valuable to quickly remedy unexpected pandemics. The abundance of functional interaction data has allowed mapping of substantial parts of the
Dimitri Guala   +2 more
doaj   +1 more source

A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma

open access: yesClinical Epigenetics, 2023
Background N-methyl-2-pyrrolidone (NMP) is an epigenetically active chemical fragment and organic solvent with numerous applications including use as a drug-delivery vehicle. Previously considered biologically inert, NMP demonstrates immunomodulatory and
Jake Shortt   +8 more
doaj   +1 more source

A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures

open access: yes, 2023
Delivering better care for patients with bladder cancer (BC) necessitates the development of novel therapeutic strategies that address both the high disease heterogeneity and the limitations of the current therapeutic modalities, such as drug low ...
Frantzi, Maria   +6 more
core   +1 more source

Drug Repurposing for Therapeutic Discovery against Human Metapneumovirus Infection

open access: yes, 2022
Human metapneumovirus (HMPV) is recognized as an important cause of pneumonia in infants, in the elderly, and in immunocompromised individuals worldwide.
Guillon, Patrice   +4 more
core   +1 more source

COVID infection in 4 steps: Thermodynamic considerations reveal how viral mucosal diffusion, target receptor affinity and furin cleavage act in concert to drive the nature and degree of infection in human COVID-19 disease

open access: yesHeliyon, 2023
We have developed a mechanistic model of SARS-CoV-2 and SARS-CoV infection, exploring the relationship between the viral diffusion in the mucosa and viral affinity for the angiotensin converting enzyme 2 (ACE2) target. Utilising the structural similarity
Marko Popovic   +2 more
doaj   +1 more source

Drug Repurposing: Then, Now, and in the Future

open access: yesDrug Repurposing, 2022
Contrary to the definition of a drug, drug repurposing usually involves the redevelopment of an active pharmaceutical ingredient (API) for a substantially different medical use; only rarely is this done with an off-the-shelf drug approved for a different disease.
openaire   +1 more source

Home - About - Disclaimer - Privacy